Insiders who have reported open-market trades at the same companies as Jacob A. Frenkel. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Chaim Lebovits - $11K in BCLI purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Jacob A. Frenkel is a corporate insider, tracked as Director of BRAINSTORM CELL THERAPEUTICS INC. (BCLI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jacob A. Frenkel submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
InsiderAlpha's records for Jacob A. Frenkel go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
